the api market
Facts and figures
What are APIs?
APIs (Active Pharmaceutical Ingredients) are responsible for the pharmaceutical effect of formulated pharmaceuticals (medicines). They are produced using highly technological industrial processes, both during the R&D and commercial production phases.
A global business
The API market is increasingly a global business integrated in the supply chain of pharmaceuticals, in which APIs constitute the most important components in terms of clinical efficacy and value.
The API market’s outlook is positive
with a healthy growth rate for the next years foreseen at
%
P.A. in the generic sector
%
P.A. in the custom sector
The growing trend towards new high tech therapeutics coupled with the emergence of novel and innovative delivery systems and the evolution of personalized medicines will only serve to further emphasise the growing demand for advanced APIs.
Merchant demand for APIs: 48 BILLION USD
%
NORTH AMERICA
%
ASIA FAR EAST
%
WESTERN EUROPE
%
REST OF THE WORLD
The demand for active pharmaceutical ingredients in Western Europe is concentrated mainly in the United Kingdom and Germany, essentially in relation to the higher proportion of sales of generics drugs in these countries.
API PRODUCTION WORLDWIDE
%
ASIA FAR EAST
%
WESTERN EUROPE
%
NORTH AMERICA
%
REST OF THE WORLD
Clients are demanding more quality and more reliability from their API sources to avoid public health risks
The trend towards outsourcing by big pharmaceutical multinationals is expected to continue growing, which will result in an increased demand for quality APIs
Companies are increasing their size to face global competition. Mergers and acquisitions are taking place in order to pursue global projects
There is a growing investment in R&D for API production processes, as well in quality, environment and safety, resulting in better, safer and cleaner technologies and substantial increase of pharmaceutical technology know-how and intellectual property
SOCIO ECONOMIC IMPACT IN EUROPE
manufacturers
jobs
